• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ACCULINK CAROTID STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ACCULINK CAROTID STENT SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Occlusion (1984); Transient Ischemic Attack (2109); Heart Failure (2206); Stenosis (2263); Prolapse (2475)
Event Date 08/06/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event has been estimated.Udi could not be reported because the part and lot numbers were not reported.Date of implant has been estimated.The device was not returned for evaluation.A review of the electronic lot history record (elhr), was not performed since the part and lot numbers were not reported and the product was not returned for analysis.The reported patient effects of cerebrovascular accident, myocardial infarction, occlusion, tia-transient ischemic attack, heart failure and stenosis are listed in rx acculink carotid stent system electronic instructions for use as known patient effects of the stenting procedure.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.Literature attachment: cguard micronet covered stent vs.Acculink: basal, 30d dw mri and 1y clinical evaluation in 100 randomized patients: the siberia trial.[(b)(4)].
 
Event Description
It was reported via a literature article identifying acculink carotid stents that may be related to myocardial infarction, stroke, restenosis, congestive heart failure, occlusion, transient ischemic attack, plaque prolapse and treatment with medication.Details are listed in the attached report titled, interim results of the randomized study in carotid artery revascularization: cguard micronet covered stent vs.Acculink: basal, 30d dw mri and 1y clinical evaluation in 100 randomized patients: the siberia trial.
 
Manufacturer Narrative
Internal file number - (b)(4).Correction: conclusion code 67 was added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCULINK CAROTID STENT SYSTEM
Type of Device
CAROTID STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8348361
MDR Text Key136490171
Report Number2024168-2019-01194
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
PMA/PMN Number
P040012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/07/2019
Initial Date FDA Received02/18/2019
Supplement Dates Manufacturer Received02/21/2019
Supplement Dates FDA Received02/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Disability;
-
-